v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net loss $ (22,054,535) $ (120,506,771)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 319,984 311,144
Change in fair value and loss on exchange of convertible notes 1,769,857 (15,500,000)
Change in fair value of Investment in LMC 0 136,605,952
Stock-based compensation 2,350,293 892,428
Write down of inventory 519,939 (361,717)
Forgiveness of PPP Term Note 0 (1,411,000)
Deferred taxes 0 (17,632,492)
Other non-cash items 310,480 0
Effects of changes in operating assets and liabilities:    
Accounts and lease receivable 98,347 (9,635)
Inventory (3,477,474) (14,842,677)
Prepaid expenses and other current assets (4,166,915) (3,813,318)
Other assets (55,661) 0
Accounts payable, accrued liabilities and other (6,088,342) 1,509,399
Warranty liability (268,453) (144,957)
Net cash used in operating activities (30,742,480) (34,903,644)
Cash flows from investing activities:    
Capital expenditures (3,595,842) (1,264,767)
Net cash used in investing activities (3,595,842) (1,264,767)
Cash flows from financing activities:    
Payments on finance lease (64,934) 0
Exercise of warrants and options and restricted share award activity (196,262) 14,220
Net cash (used in) provided by financing activities (261,196) 14,220
Change in cash and cash equivalents (34,599,518) (36,154,191)
Cash, cash equivalents and restricted cash, beginning of the period 201,647,394 241,229,067
Cash and cash equivalents, end of the period $ 167,047,876 $ 205,074,876

Source